Impact of hinge motion on in-stent restenosis after sirolimus-eluting stent implantation

Circulation Journal

Volumn 75, Issue 8, 2011, Pages 1878-1884

  Ino, Yasushi ^a   Kubo, Takashi ^a   Kitabata, Hironori ^a   Shimamura, Kunihiro ^a   Shiono, Yasutsugu ^a   Orii, Makoto ^a   Okochi, Keishi ^a   Sougawa, Hiromichi ^a   Tanimoto, Takashi ^a   Komukai, Kenichi ^a   Ishibashi, Kohei ^a   Takarada, Shigeho ^a   Nakanishi, Hiroko ^a   Tanaka, Atsushi ^a   Kimura, Keizo ^a   Hirata, Kumiko ^a   Mizukoshi, Masato ^a   Imanishi, Toshio ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hinge motion; In stent restenosis; Sirolimus eluting stent

Indexed keywords

RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIASTOLE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; SIROLIMUS ELUTING STENT; SYSTOLE;

AGED; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; MOTION; RENAL DIALYSIS; RISK FACTORS;

EID: 79960770936     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1182     Document Type: Article

References (27)

1. Gyöngyösi M, Yang P, Khorsand A, Glogar D, on behalf of the Austrian Wiktor Stent Study Group and European Paragon Stent Investigators. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. J Am Coll Cardiol 2000; 35: 1580-1589.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al.; for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
3. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al; for the SIRIUS Investigators. Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
4. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178-2180.
5. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, et al. Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanical analysis from a consecutive series of cases. Circulation 2003; 108: 257-260.
6. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004; 110: 3430-3434.
7. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 2007; 69: 380-386.
8. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, et al. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009; 73: 2036-2041.
9. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, et al. Frequency, predictors and outcome of stent fracture after sirolimuseluting stent implantation. Int J Cardiol 2009; 133: 321-326.
10. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB, et al. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol 2009; 103: 923-929.
11. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, et al. Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation. Am Heart J 2010; 160: 775e1-e9.
12. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, et al. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 2009; 103: 818-823.
13. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
14. Koo BK, Waseda K, Ako J, Hasegawa T, Shimohama T, Nakatani D, et al. Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents. Int J Cardiol 2010; 144: 132-134.
15. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: Three-year results of the RAVEL trial. Circulation 2005; 111: 1040-1044.
16. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-1370.
17. Popma JJ, Leon MB, Moses JW, Holmes DR, Cox N, Fitzpatrick M, et al. for the SIRIUS investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004; 110: 3773-3780.
18. Shirai S, Kimura T, Nobuyoshi M, Morimoto T, Ando K, j-Cypher Registry Investigators. Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-cypher registry. J Am Coll Cardiol Intv 2009; 2: 97-106.
19. Yamagata K, Kataoka Y, Kokubu N, Kasahara Y, Abe M, Nakajima H, et al. A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease. Circ J 2010; 74: 671-678.
20. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.
21. Tamekiyo H, Hayashi Y, Toyofuku M, Ueda H, Sakuma T, Okimoto T, et al. Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy. Circ J 2009; 73: 2042-2049.
22. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525-1529.
23. Mori S, Yasuda S, Kataoka Y, Morii I, Kawamura A, Miyazaki S. Significant association of coronary artery calcification in stent delivery route with restenosis after sirolimus-eluting stent implantation. Circ J 2009; 73: 1856-1863.
24. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252.
25. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 1986; 43: 139-143.
26. Carrozza JP Jr, Hosley SE, Cohen DJ, Baim DS. In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: Differential outcome by stent design. Circulation 1999; 100: 756-760.
27. Tsunoda T, Nakamura M, Wada M, Ito N, Kitagawa Y, Shiba M, et al. Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis 2004; 15: 39-44.